Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Swanson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2023
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional studyChad Tang, Jeremiah Sanders, Howard Thames, et al.
Clinical and Translational Radiation Oncology|September 23, 2024
Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanomaSydney A Keatts, Aya F Salem, David M Swanson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2024
Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast CancerLuisa E Jacomina, David M Swanson, Melissa P Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects-A Phase 2 Clinical TrialSimona F Shaitelman, Huong Le-Petross, Maria G Raso, et al.
Cancer|August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomesAndrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
Clinical and Translational Radiation Oncology|August 27, 2024
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer centerAlan J Sosa, Michael K Rooney, Howard D Thames, et al.
Lancet (London, England)|December 14, 2025
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trialSteven J Frank, Paul M Busse, J Jack Lee, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2023
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional studyChad Tang, Jeremiah Sanders, Howard Thames, et al.
Clinical and Translational Radiation Oncology|September 23, 2024
Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanomaSydney A Keatts, Aya F Salem, David M Swanson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2024
Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast CancerLuisa E Jacomina, David M Swanson, Melissa P Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects-A Phase 2 Clinical TrialSimona F Shaitelman, Huong Le-Petross, Maria G Raso, et al.
Cancer|August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomesAndrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
Clinical and Translational Radiation Oncology|August 27, 2024
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer centerAlan J Sosa, Michael K Rooney, Howard D Thames, et al.
Lancet (London, England)|December 14, 2025
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trialSteven J Frank, Paul M Busse, J Jack Lee, et al.
Pageof 2